Publications by authors named "S G Bihari"

Objective: To compare the effects of fluid bolus therapy (FBT) with 20% albumin to crystalloid FBT on the incidence of cardiac surgery-associated acute kidney injury (CSA-AKI) and its severity and duration.

Design: Secondary analysis of the multicenter, parallel-group, open-label, randomized HAS FLAIR-II trial.

Setting: Six intensive care units.

View Article and Find Full Text PDF
Article Synopsis
  • The study introduces a new passive device that regulates expiratory flow, which is important because unregulated flow can lead to lung injury in patients on mechanical ventilation.
  • It tested the device against various mechanical ventilation settings, finding significant reductions in peak expiratory flow, expiratory time, and dissipated energy, all of which can indicate less risk of lung injury.
  • Results showed a major decrease in peak expiratory flow and dissipated energy per breath, highlighting the device's effectiveness in improving ventilation safety without needing computer control or initial triggers.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates acute respiratory distress syndrome (ARDS) in ICU patients from Australia and New Zealand, focusing on patient characteristics and management practices during a multi-center analysis.
  • Among the 200 participants, the average age was 55.5 years; notable findings included a low adherence to lung protective ventilation (only 10.5% on day one) and significant use of adjunctive therapies like systemic steroids.
  • The in-hospital mortality rate by day 28 was 30.5%, highlighting the need for improved implementation of established treatment protocols in ARDS care.
View Article and Find Full Text PDF

The rat is a useful laboratory model for respiratory diseases. SARS-CoV-2 proteins, such as the spike (S) protein, can induce inflammation. This study has investigated the ability of the Q498Y, P499T (QP-YT) amino acid change, described in the S-protein of the mouse-adapted laboratory SARS-CoV-2 MA strain, to interact with rat angiotensin converting enzyme-2 (ACE2) and stimulate responses in rat lungs.

View Article and Find Full Text PDF